Calcium channel blocker/en: Difference between revisions
Calcium channel blocker/en
Updating to match new version of source page |
Updating to match new version of source page |
||
Line 89: | Line 89: | ||
|- | |- | ||
|} | |} | ||
{| class="wikitable sortable" style="width:100%" | |||
|+非ジヒドロビリジン系 | |||
|- | |||
!一般名 | |||
!先発名 | |||
!class="unsortable"| 日本 | |||
!創薬/開発 | |||
!備考 | |||
|- | |||
|[[Diltiazem/ja]] | |||
|[https://medical.mt-pharma.co.jp/di/product/her/ ヘルベッサー](Herbesser) ([https://pins.japic.or.jp/pdf/newPINS/00050628.pdf PI]) ([https://medical.mt-pharma.co.jp/di/file/if/f_her_d.pdf IF]) | |||
|販売 | |||
|[[Mitsubishi Tanabe Pharma|田辺製薬]] | |||
|持効製剤のRと注射剤もあり | |||
|- | |||
|} | |||
<languages /> | <languages /> | ||
{{Pathnav|Medication|Antihypertensive drug|frame=1}} | {{Pathnav|Medication|Antihypertensive drug|frame=1}} |